Koesten, Hirschmann & Crabtree, Inc. Avanos Medical, Inc. Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $192 Million
- Q2 2025
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 23 shares of AVNS stock, worth $271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$271% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVNS
# of Institutions
311Shares Held
44.5MCall Options Held
0Put Options Held
21.8K-
Black Rock Inc. New York, NY7.01MShares$82.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$52.6 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4MShares$47.1 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$30.4 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.04MShares$24 Million0.44% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $548M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...